tiprankstipranks
Trending News
More News >
NeoGenomics (NEO)
NASDAQ:NEO

NeoGenomics (NEO) Stock Statistics & Valuation Metrics

Compare
1,856 Followers

Total Valuation

NeoGenomics has a market cap or net worth of $990.95M. The enterprise value is $1.46B.
Market Cap$990.95M
Enterprise Value$1.46B

Share Statistics

NeoGenomics has 128,694,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding128,694,500
Owned by Insiders1.04%
Owned by Institutions0.13%

Financial Efficiency

NeoGenomics’s return on equity (ROE) is -0.09 and return on invested capital (ROIC) is -5.85%.
Return on Equity (ROE)-0.09
Return on Assets (ROA)-0.05
Return on Invested Capital (ROIC)-5.85%
Return on Capital Employed (ROCE)-0.07
Revenue Per Employee300.26K
Profits Per Employee-35.78K
Employee Count2,200
Asset Turnover0.40
Inventory Turnover13.85

Valuation Ratios

The current PE Ratio of NeoGenomics is -5.30. NeoGenomics’s PEG ratio is 0.46.
PE Ratio-5.30
PS Ratio0.00
PB Ratio0.46
Price to Fair Value0.46
Price to FCF-12.26
Price to Operating Cash Flow59.44
PEG Ratio0.46

Income Statement

In the last 12 months, NeoGenomics had revenue of 660.57M and earned -78.73M in profits. Earnings per share was -3.10.
Revenue660.57M
Gross Profit290.10M
Operating Income-92.11M
Pretax Income-80.67M
Net Income-78.73M
EBITDA-1.51M
Earnings Per Share (EPS)-3.10

Cash Flow

In the last 12 months, operating cash flow was 7.61M and capital expenditures -39.98M, giving a free cash flow of -32.37M billion.
Operating Cash Flow7.61M
Free Cash Flow-32.37M
Free Cash Flow per Share-0.25

Dividends & Yields

NeoGenomics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.17
52-Week Price Change-50.35%
50-Day Moving Average9.53
200-Day Moving Average13.98
Relative Strength Index (RSI)39.30
Average Volume (3m)2.66M

Important Dates

NeoGenomics upcoming earnings date is Jul 30, 2025, TBA Not Confirmed.
Last Earnings DateApr 29, 2025
Next Earnings DateJul 30, 2025
Ex-Dividend Date

Financial Position

NeoGenomics as a current ratio of 1.98, with Debt / Equity ratio of 68.09%
Current Ratio1.98
Quick Ratio1.89
Debt to Market Cap1.30
Net Debt to EBITDA-157.72
Interest Coverage Ratio-13.92

Taxes

In the past 12 months, NeoGenomics has paid -1.95M in taxes.
Income Tax-1.95M
Effective Tax Rate0.02

Enterprise Valuation

NeoGenomics EV to EBITDA ratio is -1.54K, with an EV/FCF ratio of -68.32.
EV to Sales3.52
EV to EBITDA-1.54K
EV to Free Cash Flow-68.32
EV to Operating Cash Flow331.15

Balance Sheet

NeoGenomics has $358.08M in cash and marketable securities with $604.78M in debt, giving a net cash position of $246.70M billion.
Cash & Marketable Securities$358.08M
Total Debt$604.78M
Net Cash$246.70M
Net Cash Per Share$1.92
Tangible Book Value Per Share$0.31

Margins

Gross margin is 43.79%, with operating margin of -13.94%, and net profit margin of -11.92%.
Gross Margin43.79%
Operating Margin-13.94%
Pretax Margin-12.21%
Net Profit Margin-11.92%
EBITDA Margin-0.23%
EBIT Margin-11.21%

Analyst Forecast

The average price target for NeoGenomics is $13.05, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$13.05
Price Target Upside69.48% Upside
Analyst ConsensusModerate Buy
Analyst Count14
Revenue Growth Forecast10.10%
EPS Growth Forecast8.79%

Scores

Smart Score4
AI Score52
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis